April 22, 2010 - ZOLL Honored for Excellence in Customer Service for Ninth Year


A. Ernest Whiton
Chief Financial Officer
ZOLL Medical Corporation
+1 (978) 421-9655


Diane Egan
ZOLL Medical Corporation
+1 (978) 421-9637


Company receives Omega NorthFace ScoreBoard Award for Technical Support and Customer Service

April 22, 2010CHELMSFORD, MASS.– ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that it is one of only four companies to receive the Omega NorthFace ScoreBoard AwardSM for the ninth consecutive year for excellence in customer satisfaction. Now in its tenth year, the award is presented annually by the Omega Management Group Corporation to organizations that, as rated solely by their own customers, achieved excellence in customer service and support during the prior calendar year.  

ZOLL has qualified for the award nine times for its Technical Support, and was also honored for a second consecutive year in the areas of Customer Service and Shipping and Delivery.  According to Omega, the awards in each category "demonstrate an ongoing commitment to building profitable, long-term customer loyalty by exceeding customer expectations." 

"Since 2000, ZOLL’s customer satisfaction levels for technical support and customer service have consistently remained high," said Jonathan A. Rennert, President of ZOLL. “This type of consistency year after year clearly demonstrates the importance we place on customer service as we develop products that help advance the practices of resuscitation and critical care.” 

“Due to its unique ‘customer-only vote’ criteria, the NorthFace ScoreBoard Award has been viewed from its inception as the only objective benchmark for excellence in customer service,” said John Alexander Maraganis, President and CEO of Omega.  “In 2009, more than 200 projects, many international in scope, were judged from 58 companies based in the U.S. and abroad. The majority of companies are repeat recipients, which shows that, despite the tough economy, implementing a Customer Experience Management strategy is a reliable, proven way to achieve business success.”

 To qualify organizations for the award, Omega’s methodology measures customer satisfaction and loyalty levels on a 5-point scale four times during the year.  NorthFace ScoreBoard Award recipients are companies who, based solely on survey responses from their own customers, achieved a 4.0 or above out of a possible 5.0.\

About Omega

Since 1984, the Omega Management Group Corp. has been a recognized expert in developing and implementing customer and employee experience management strategy (CEM) programs that lead to increased product and service revenue and profits. Services include customer and employee surveys, employee incentive programs, benchmark research and analysis, consulting, key account retention strategies, win-back strategies; and marketing of customer satisfaction results to stakeholders and the marketplace. For more information, visit www.omegascoreboard.com

About ZOLL Medical Corporation

ZOLL Medical Corporation develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.  

A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company for the past three years, ZOLL develops and manufactures its products in the United States, in California, Colorado, Illinois, Massachusetts, Pennsylvania, and Rhode Island. More than 400 direct sales and service representatives, 1,100 business partners, and 200 independent representatives serve our customers in over 140 countries around the globe.  For more information, visit www.zoll.com.

Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company's   Quarterly Report on Form 10-Q filed with the SEC on February 11, 2010. You should not place undue reliance on the forward looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements.

©2010 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105.  ZOLL is a registered trademark of ZOLL Medical Corporation. NorthFace ScoreBoard Award is a service mark of Omega Management Group Corporation.